The GAO has published a report based on a review of FDA’s strategic planning and management. The report examined the extent to which: (1) FDA’s Strategic Action Plan addresses management challenges and the agency’s progress; (2) FDA’s annual performance measures are results-oriented; (3) FDA has aligned its activities and resources to support its strategic goals; and (4) FDA managers report using performance information in decision-making and applying key practices to encourage that use. GAO recommends that FDA take several steps to improve strategic planning and management, such as developing a strategic human capital plan and working to make the agency’s performance measures more results-oriented. FDA concurred with the GAO’s recommendations.